Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
29.55
-0.62 (-2.06%)
At close: Mar 9, 2026
SHA:688217 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 139.19 | 161.95 | 204.22 | 123.76 |
Trading Asset Securities | - | 93.53 | 72.36 | 90.61 | 201.11 |
Cash & Short-Term Investments | 218.3 | 232.72 | 234.31 | 294.83 | 324.88 |
Cash Growth | -6.20% | -0.68% | -20.53% | -9.25% | 127.88% |
Accounts Receivable | - | 171.26 | 187.96 | 256.42 | 164.54 |
Other Receivables | - | 11.39 | 11.07 | 4.42 | 7.03 |
Receivables | - | 182.66 | 199.03 | 260.84 | 171.57 |
Inventory | - | 43.4 | 60.65 | 53.96 | 37.27 |
Other Current Assets | - | 11.36 | 15.9 | 14.86 | 22.58 |
Total Current Assets | - | 470.14 | 509.9 | 624.48 | 556.3 |
Property, Plant & Equipment | - | 366.12 | 365.34 | 276.01 | 212.77 |
Long-Term Investments | - | 47.92 | 47.76 | 56.76 | 56.76 |
Goodwill | - | 11.12 | 25.43 | 32.92 | 46.31 |
Other Intangible Assets | - | 41.06 | 49.61 | 40.04 | 46.35 |
Long-Term Deferred Tax Assets | - | 20.86 | 16.7 | 10.26 | 3.94 |
Long-Term Deferred Charges | - | 2.03 | 1.96 | 0.93 | 3.01 |
Other Long-Term Assets | - | 26.45 | 27.46 | 42.46 | 22.09 |
Total Assets | - | 985.7 | 1,044 | 1,084 | 947.53 |
Accounts Payable | - | 11.27 | 14.37 | 51.18 | 11.18 |
Accrued Expenses | - | 14.2 | 17.62 | 21.42 | 13.4 |
Short-Term Debt | - | 1.51 | 1.51 | 2.86 | 0.88 |
Current Portion of Leases | - | 5.41 | 5.82 | 2.97 | 4.7 |
Current Income Taxes Payable | - | 2.18 | 0.11 | 7.41 | 0.26 |
Current Unearned Revenue | - | 2.12 | 2 | 2.84 | 1.7 |
Other Current Liabilities | - | 2.03 | 1.18 | 1.42 | 1.32 |
Total Current Liabilities | - | 38.72 | 42.61 | 90.09 | 33.44 |
Long-Term Debt | - | 13.75 | 16.25 | - | - |
Long-Term Leases | - | 1.75 | 5.75 | 8.1 | 3.96 |
Long-Term Unearned Revenue | - | 1.34 | 1.68 | 2.02 | 4.35 |
Long-Term Deferred Tax Liabilities | - | 4.91 | 6.81 | 8.16 | 5.52 |
Other Long-Term Liabilities | - | 4.59 | 3.39 | 4.08 | 3.6 |
Total Liabilities | - | 65.06 | 76.48 | 112.45 | 50.87 |
Common Stock | - | 55.86 | 55.86 | 55.58 | 55.58 |
Additional Paid-In Capital | - | 732.16 | 735.89 | 725.16 | 717.56 |
Retained Earnings | - | 138.26 | 154.03 | 156.16 | 115.68 |
Treasury Stock | - | -17.03 | - | - | - |
Total Common Equity | 903.64 | 909.26 | 945.78 | 936.9 | 888.81 |
Minority Interest | - | 11.39 | 21.9 | 34.53 | 7.85 |
Shareholders' Equity | 908.34 | 920.64 | 967.68 | 971.42 | 896.67 |
Total Liabilities & Equity | - | 985.7 | 1,044 | 1,084 | 947.53 |
Total Debt | 2.54 | 22.42 | 29.33 | 13.92 | 9.53 |
Net Cash (Debt) | 215.76 | 210.3 | 204.98 | 280.91 | 315.35 |
Net Cash Growth | 2.60% | 2.60% | -27.03% | -10.92% | 121.80% |
Net Cash Per Share | 3.89 | 3.74 | 3.62 | 5.07 | 6.33 |
Filing Date Shares Outstanding | 53.09 | 55.19 | 55.86 | 55.58 | 55.58 |
Total Common Shares Outstanding | 55.19 | 55.19 | 55.86 | 55.58 | 55.58 |
Working Capital | - | 431.42 | 467.29 | 534.39 | 522.86 |
Book Value Per Share | 16.37 | 16.48 | 16.93 | 16.86 | 15.99 |
Tangible Book Value | 858.56 | 857.08 | 870.74 | 863.93 | 796.15 |
Tangible Book Value Per Share | 15.56 | 15.53 | 15.59 | 15.54 | 14.33 |
Buildings | - | 270.1 | 267.52 | 88.44 | 88.44 |
Machinery | - | 187.48 | 180.06 | 168.75 | 145.41 |
Construction In Progress | - | 69.94 | 43.24 | 115.68 | 58.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.